Drug Metabolism, Poor, CYP2D6-Related
Drug Metabolism, Poor, CYP2D6-Related
Explore linked clinical trials. Standard reference: MESH:M05641353 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: | Drug Metabolism, Poor, CYP2C19-Related, Drug Metabolism, Poor, CYP2D6-Related | Recruiting | Phase 2 | 2025-10-14 | NCT06322238 | |
| Methadone Dose Monitoring With a Remote Medication Monitor | Chronic Pain, Drug Metabolism, Poor, CYP2D6-Related, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Not stated | 2025-02-20 | NCT06837571 | |
| Assessment of Methadone Dose Taken | Chronic Pain, Drug Metabolism, Poor, CYP2D6-Related, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not stated | 2025-02-13 | NCT05981573 |